Background
==========

The substituted hydroxynaphthoquinone atovaquone is a potent antimalarial drug in use for prevention and therapy, a fundamental part of the ongoing global medicinal strategy to control the disastrous infectious disease. Atovaquone acts via inhibition of the cytochrome *bc*~1~ complex (cyt *bc*~1~) and related mutations were linked to parasitic drug-resistance.

Materials and methods
=====================

The molecular binding mode of atovaquone was analysed by spectroscopy and X-ray crystallography. In addition, a comprehensive cytochrome *b* sequence analysis was performed to interpret binding interactions of the drug in context of sequence conservation of Qo site amino acid residues \[[@B1],[@B2]\].

Results
=======

We determined the 3.0-Å resolution X-ray structure of mitochondrial cyt *bc*~1~ from *Saccharomyces cerevisiae* with atovaquone bound in the catalytic Qo site \[[@B1]\]. The drug, which has a pK~a~ of 6.9, forms a polarized H-bond between its ionized hydroxyl group and His181 of the Rieske protein subunit. Multiple non-polar interactions with side chains of cytochrome *b* residues stabilize hydroxynaphthoquinone and chlorophenyl-cyclohexyl groups. The cytochrome *b* sequence analysis showed that the majority of the interacting residues are conserved, so that atovaquone binding to the yeast cyt *bc*~1~ is likely to resemble the binding to the complexes of the target organisms.

Conclusion
==========

The binding mode provides detailed insights in the molecular basis of broad target spectrum, species-specific efficacies and acquired resistances. This may aid drug development to control the spread of drug-resistant parasites.
